Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of $123.46 billion. The enterprise value is $135.37 billion.
Important Dates
The last earnings date was Thursday, April 24, 2025, before market open.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | May 9, 2025 |
Share Statistics
Sanofi has 1.23 billion shares outstanding. The number of shares has decreased by -0.31% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.23B |
| Shares Change (YoY) | -0.31% |
| Shares Change (QoQ) | -1.57% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 1.10B |
Valuation Ratios
The trailing PE ratio is 9.37 and the forward PE ratio is 11.04.
| PE Ratio | 9.37 |
| Forward PE | 11.04 |
| PS Ratio | 2.53 |
| Forward PS | 3.43 |
| PB Ratio | 1.47 |
| P/TBV Ratio | 5.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 19.88 |
| EV / Sales | 2.77 |
| EV / EBITDA | 10.31 |
| EV / EBIT | 13.33 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.44 |
| Debt / FCF | n/a |
| Interest Coverage | 17.14 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 6.23% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $589,029 |
| Profits Per Employee | $82,148 |
| Employee Count | 82,878 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Sanofi has paid $1.71 billion in taxes.
| Income Tax | 1.71B |
| Effective Tax Rate | 20.10% |
Stock Price Statistics
The stock price has increased by +3.61% in the last 52 weeks. The beta is 0.43, so Sanofi's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | +3.61% |
| 50-Day Moving Average | 54.48 |
| 200-Day Moving Average | 53.10 |
| Relative Strength Index (RSI) | 42.79 |
| Average Volume (20 Days) | 3,086,365 |
Short Selling Information
The latest short interest is 3.56 million, so 0.29% of the outstanding shares have been sold short.
| Short Interest | 3.56M |
| Short Previous Month | 3.95M |
| Short % of Shares Out | 0.29% |
| Short % of Float | 0.32% |
| Short Ratio (days to cover) | 1.29 |
Income Statement
In the last 12 months, Sanofi had revenue of $48.82 billion and earned $6.81 billion in profits. Earnings per share was $5.45.
| Revenue | 48.82B |
| Gross Profit | 34.64B |
| Operating Income | 10.15B |
| Pretax Income | n/a |
| Net Income | 6.81B |
| EBITDA | 13.13B |
| EBIT | 10.15B |
| Earnings Per Share (EPS) | $5.45 |
Full Income StatementBalance Sheet
The company has $8.17 billion in cash and $19.36 billion in debt, giving a net cash position of -$11.19 billion or -$9.07 per share.
| Cash & Cash Equivalents | 8.17B |
| Total Debt | 19.36B |
| Net Cash | -11.19B |
| Net Cash Per Share | -$9.07 |
| Equity (Book Value) | 84.15B |
| Book Value Per Share | 66.83 |
| Working Capital | n/a |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 70.96%, with operating and profit margins of 20.80% and 13.95%.
| Gross Margin | 70.96% |
| Operating Margin | 20.80% |
| Pretax Margin | 17.41% |
| Profit Margin | 13.95% |
| EBITDA Margin | 26.90% |
| EBIT Margin | 20.80% |
| FCF Margin | n/a |